首页> 外国专利> MONKEY MONOCLONAL ANTIBODIES SPECIFIC TO HUMAN B7.1 AND/OR B7.2,PRIMATIZED FORMS THEREOF,PHARMACEUTICAL COMPOS ITIONS CONTAINING, AND USE THEREOF AS IMMUNOSUPPRESSANTS

MONKEY MONOCLONAL ANTIBODIES SPECIFIC TO HUMAN B7.1 AND/OR B7.2,PRIMATIZED FORMS THEREOF,PHARMACEUTICAL COMPOS ITIONS CONTAINING, AND USE THEREOF AS IMMUNOSUPPRESSANTS

机译:特定于人类B7.1和/或B7.2的猴单克隆抗体,其原始形式,所含药物成分以及用作免疫抑制剂

摘要

THE PRESENT INVENTION RELATES TO THE IDENTIFICATION OF MACAQUE ANTIBODIES TO HUMAN B7.1 AND B7.2 Y SCREENING OF PHAGE DISPLAY LIBRARIES OR MONKEY HETEROHYBRIDOMAS OBTAINED USING B LYMPHOCYTES FROM B7.1 AND/OR B7.2 IMMUNIZED MONKEYS. MORE SPECIFICALLY, THE INVENTION PROVIDES FOUR MONKEY MONOCLONAL ANTIBODIES 7B6, 16C10, 7C10 AND 20C9 WHICH INHIBIT THE B7:CD28 PATHWAY AND THEREBY FUNCTION AS EFFECTIVE IMMUNOSUPPRESSANTS. THE INVENTION FURTHER PROVIDES THE COMPLETE DNA AND AMINO ACID SEQUENCES OF THE LIGHT AND HEAVY CHAIN OF THREE PRIMATIZED ANTIBODIES DERIVED FROM THOSE MONKEY MONOCLONAL ANTIBODIES WHICH BIND B7.1 AND POSSIBLY B7.2, PRIMATIZED 7C10, PRIMATIZED 7B6 AND PRIMATIZED 16C10. THESE PRIMATIZED AND MONKEY ANTIBODIES MAY BE USED AS SPECIFIC IMMUNOSUPPRESSANTS, E.G., FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND TO PREVENT ORGAN TRANSPLANT REJECTION.
机译:本发明涉及猕猴对人B7.1和B7.2的噬菌体展示文库或使用来自B7.1和/或B7.2受免疫的猴的B淋巴细胞获得的猴杂种杂交的Y筛选的鉴定。更具体地讲,本发明提供了四种抑制B7:CD28途径的猴子单抗7B6、16C10、7C10和20C9,因此具有作为有效的免疫抑制剂的功能。本发明还提供了三种新的完整的DNA和氨基酸序列,所述轻和重的链是由这些B7.1和B7.2,分别为7C10,已主化的77.10,B7和10。这些主要和猴子的抗体可以用作特定的免疫抑制剂,例如,用于治疗自身免疫性疾病和预防器官移植。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号